Question 1

Who are the top researchers at Arvinas (United States)?

Accepted Answer

Ranked on the quality score, Hanqing Dong, Andrew P. A. Crew and Tom Januario lead among researchers whose main affiliation is Arvinas (United States).

Question 2

What are the most cited papers from Arvinas (United States)?

Accepted Answer

The most cited paper from Arvinas (United States) is "PROTAC targeted protein degraders: the past is prologue" (Miklós Békés, David R. Langley, Craig M. Crews, 2022), with 3,294 citations. Next come "Catalytic in vivo protein knockdown by small-molecule PROTACs" (1,365) and "Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4" (1,162).

Question 3

Which research topics does Arvinas (United States) publish most on?

Accepted Answer

By volume in 2022-now: Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, HER2/EGFR in Cancer Research and Advanced Breast Cancer Therapies.

Question 4

Which keywords describe research at Arvinas (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Transcriptional Regulation, BET Bromodomains, PROTACs, Cancer Therapy, Breast Cancer, PET Imaging, Tumor Microenvironment and Fibroblast Activation Protein.

Question 5

Which fields of science does Arvinas (United States) work in?

Accepted Answer

In 2022-now, 46% of research at Arvinas (United States) is in Health Sciences, 46% in Life Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (44%), Chemistry (2%). It does 2.6× the world's share of Life Sciences.

Question 6

Is Arvinas (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 121% higher than in 2018-2021.